Tag Archives: cytokine storm

Spray and pray – the COVID-19 version

Posted on September 1, 2020 by VM

Kiran Mazumdar-Shaw is the head of Biocon, a company headquartered in Bengaluru and which has repurposed a drug called itolizumab – already approved to help manage severe chronic psoriasis in different markets – to manage cytokine release syndrome (CRS) in … Continue reading →

Posted in Science | Tagged azithromycin, Biocon, chyavanprash, COVID-19, cytokine release syndrome, cytokine storm, favipiravir, hydroxychloroquine, Itolizumab, Kiran Mazumdar-Shaw, novel coronavirus, psoriasis, The Print | Leave a comment

Tag Archives: cytokine storm

Spray and pray – the COVID-19 version

Sign up

Recent posts